Patents Assigned to CV Theapeutics, Inc.
  • ABCA-1 elevating compounds
    Patent number: 6919339
    Abstract: The present invention provides compounds that elevate cellular expression of the ABCA-1 gene, promoting cholesterol efflux from cells and increasing HDL levels in the plasma of a mammal, in particular humans. The compounds are useful for treating coronary artery disease.
    Type: Grant
    Filed: December 4, 2001
    Date of Patent: July 19, 2005
    Assignee: CV Theapeutics, Inc.
    Inventors: Michael Campbell, Prabha N. Ibrahim, Jeff A. Zablocki, Richard Lawn